| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE MAGNESIUM | 22 |
| 1 | OMEPRAZOLE MAGNESIUM | 21 |
| 2 | LANSOPRAZOLE | 15 |
| 3 | OMEPRAZOLE | 15 |
| 4 | OCTREOTIDE ACETATE | 14 |
| 5 | EVEROLIMUS | 12 |
| 6 | EVEROLIMUS TABLETS | 10 |
| 7 | TEMOZOLOMIDE | 9 |
| 8 | CAPECITABINE | 8 |
| 9 | VONOPRAZAN FUMARATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVAMLODIPINE | 1 | 0.0080 |
| 1 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 2 | METYRAPONE | 1 | 0.0010 |
| 3 | VONOPRAZAN FUMARATE | 8 | 0.0010 |
| 4 | MIGLUSTAT | 1 | 0.0009 |
| 5 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 6 | EVEROLIMUS TABLETS | 10 | 0.0006 |
| 7 | TELOTRISTAT ETHYL | 3 | 0.0005 |
| 8 | LUTETIUM LU 177 DOTATATE | 3 | 0.0005 |
| 9 | PLECANATIDE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 5 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 8 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |